The World Health Organization unveiled a six-month plan to respond to the current Bundibugyo Ebola outbreak, centering on scaling point-of-care molecular diagnostics and strengthening reference lab capacity. WHO estimated the plan’s total investment at about $518 million and said it will expand use of a point-of-care PCR system from South Korea-based KH Medical while improving diagnostic testing and sequencing-based surveillance across partner networks.